Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

ASCVD: later-stage trial registry

2 of 6 indexed ASCVD trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

ASCVD: 6 US clinical trials tracked, 2 recruiting.

ASCVD is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition ascvd

OPEN 2 | RECR 33% | LATE 1 | EARLY 0 | RANK #2866 | SPON 3

Volume-matched condition peers

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%ASCVD (this)33%
Open-enrollment share among volume-matched conditions near ASCVD

ASCVD lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for ASCVD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. ASCVD is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates ASCVD research.

    Brigham and Women's Hospital accounts for 3 of 6 trials (50%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical ASCVD enrolment sits around 400 participants.

    Median target enrolment is 400 among the 6 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. ASCVD splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Brigham and Women's Hospital 3 trials
Duke University 2 trials
Stanford University 1 trials

Named interventions

Most-linked intervention names on ASCVD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Alert Behavioral
1 trials
Notification of patients and clinicians Other
1 trials
Pharmacist call Other
1 trials
Dulaglutide Drug
1 trials
Care Champion Intervention Other
1 trials
GLP-1 receptor agonist Drug
1 trials
SGLT2 inhibitor Drug
1 trials
Semaglutide Drug
1 trials

US sites by state

Facility locations filed on ASCVD trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Minnesota 2 trials
Massachusetts 2 trials
Wisconsin 1 trials
Tennessee 1 trials
South Carolina 1 trials
New York 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this ASCVD page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This ASCVD condition card totals 6 registered trials; most-linked intervention Alert; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.